Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Brand
Brand / product

Quinine

Quinine bisulfate · 300 mg

ShareSend this page
Official DRAP price PKR 538.88 10 x 10's
PKR 5.39 / tablet
✓ DRAP listed · Verified 2026-08-08
Unit-price intelligence

Equivalent price position

Same generic · strength · dosage form · compatible unit
Highest unit pricePKR 5.39/ tablet
Unit-price rangePKR 0.92–5.39/ tablet
Comparable alternatives4current-price listings
This brandPKR 5.39 / tablet
484.2% above lowest unit price
Low
High
Compare equivalent brands 5 comparable presentations
BrandCompanyPackOfficial pack priceUnit price
Quinine Bi-Sulphate Lahore Chemical and Pharmaceutical Works Pvt. Ltd. 100's PKR 92.24 PKR 0.92/ tablet
Quinine Bisulphate VENUS PHARMA 200's PKR 543.19 PKR 2.72/ tablet
Quinine Bisulphate VENUS PHARMA 100's PKR 271.60 PKR 2.72/ tablet
Quinine Bisulphate VENUS PHARMA 10x10 PKR 291.97 PKR 2.92/ tablet
Quinine This brand Glitz Pharma 10 x 10's PKR 538.88 PKR 5.39/ tablet

Comparison is calculated from current listed prices and normalized pack quantities. Products with a different strength, dosage form, or incompatible/ambiguous pack unit are excluded.

Product details

Generic
Quinine bisulfate
Therapeutic area
Anti-infectives
Drug class
Antimalarials
ATC
Strength
300 mg
Dosage form
Tablet
Pack
10 x 10's
Registration no.
038574
Verification
2026-08-08

Manufacturer

Glitz Pharma

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →
Traceability

Official price history

AmountEffective fromVerifiedSourceStatus
PKR 538.882025-09-042026-08-08DRAP PharmaPrice IndexCurrent
Same generic

Other listed brands

Price note: Unit-price comparisons are informational calculations from source-listed pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.